Bio-Techne Corporation (United States) is listed on the Nasdaq and has a market capitalization of $11.18 billion, with shareholders equity totaling $2.09 billion.
The company employs approximately 2.300 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Bio-Techne Corporation reported $1.21 billion in revenue, generating net income of $109.57 million.
Key financial metrics include a P/E ratio of 102.07, a price-to-book (P/B) ratio of 5.36, and a trailing twelve-month dividend yield of 0.45%.
The company trades under the ticker TECH.